Inhibiting ADAM17 enhances the efficacy of olaparib in ovarian cancer spheroids.
Rogmans C, Dittrich J, Hamm E, Weimer JP, Holthaus D, Arnold N, Flörkemeier I, Maass N, Jansen P, Dempfle A, Bauerschlag DO, Hedemann N.
Rogmans C, et al. Among authors: hamm e.
Sci Rep. 2024 Nov 6;14(1):26926. doi: 10.1038/s41598-024-78442-y.
Sci Rep. 2024.
PMID: 39506058
Free PMC article.